GxP Conversations · GxP Conversations

GxP Conversations Podcast Ep 22: What Are Biosimilars? Development, Stability and Clinical Practice

What makes a biosimilar different from a conventional generic medicine? GxP Conversations Episode 22 explores biosimilar development, stability and clinical practice, with a focus on oncology and the quality systems supporting biological medicines.

19:55Published 21 June 2026
GxP Conversations Podcast Ep 22: What Are Biosimilars? Development, Stability and Clinical Practice19:55

Opens in a new tab. Keep this page for the lesson notes and related learning.

Continue the conversation.

Hosted by Help Me GxP co-creators Kyle Winn and Adam Walker. Explore the full series for conversations about pharmaceutical quality, GMP, GDP and the guidance behind everyday practice.

Episodes reflect the material discussed at the time of recording. Check the current official guidance for the requirements that apply to your work.

Browse more podcast episodes or explore our guidance and reference hub.